Richard A. Fair, President and CEO at BELLICUM PHARMACEUTICALS, INC (BLCM), bought 20,000 shares at $0.99 ($20K) on 2019-08-21, disclosed to the SEC on 2019-08-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |